FACT and Ubp10 collaborate to modulate H2B deubiquitination and nucleosome dynamics

  1. Melesse Nune
  2. Michael T Morgan
  3. Zaily Connell
  4. Laura McCullough
  5. Muhammad Jbara
  6. Hao Sun
  7. Ashraf Brik
  8. Tim Formosa  Is a corresponding author
  9. Cynthia Wolberger  Is a corresponding author
  1. Johns Hopkins University School of Medicine, United States
  2. University of Utah School of Medicine, United States
  3. Technion-Israel Institute of Technology, Israel

Abstract

Monoubiquitination of histone H2B (H2B-Ub) plays a role in transcription and DNA replication, and is required for normal localization of the histone chaperone, FACT. In yeast, H2B-Ub is deubiquitinated by Ubp8, a subunit of SAGA, and Ubp10. Although they target the same substrate, loss of Ubp8 and Ubp10 cause different phenotypes and alter the transcription of different genes. We show that Ubp10 has poor activity on yeast nucleosomes, but that the addition of FACT stimulates Ubp10 activity on nucleosomes and not on other substrates. Consistent with a role for FACT in deubiquitinating H2B in vivo, a FACT mutant strain shows elevated levels of H2B-Ub. Combination of FACT mutants with deletion of Ubp10, but not Ubp8, confers increased sensitivity to hydroxyurea and activates a cryptic transcription reporter, suggesting that FACT and Ubp10 may coordinate nucleosome assembly during DNA replication and transcription. Our findings reveal unexpected interplay between H2B deubiquitination and nucleosome dynamics.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Melesse Nune

    Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, United States
    Competing interests
    No competing interests declared.
  2. Michael T Morgan

    Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, United States
    Competing interests
    No competing interests declared.
  3. Zaily Connell

    Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  4. Laura McCullough

    Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  5. Muhammad Jbara

    Schulich Faculty of Chemistry, Technion-Israel Institute of Technology, Haifa, Israel
    Competing interests
    No competing interests declared.
  6. Hao Sun

    Schulich Faculty of Chemistry, Technion-Israel Institute of Technology, Haifa, Israel
    Competing interests
    No competing interests declared.
  7. Ashraf Brik

    Schulich Faculty of Chemistry, Technion-Israel Institute of Technology, Haifa, Israel
    Competing interests
    No competing interests declared.
  8. Tim Formosa

    Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, United States
    For correspondence
    tim@biochem.utah.edu
    Competing interests
    Tim Formosa, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8477-2483
  9. Cynthia Wolberger

    Department of Biophysics and Biophysical Chemnistry, Johns Hopkins University School of Medicine, Baltimore, United States
    For correspondence
    cwolberg@jhmi.edu
    Competing interests
    Cynthia Wolberger, Reviewing editor, eLifeon the scientific advisory board of ThermoFisher Scientific.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8578-2969

Funding

National Institute of General Medical Sciences (GM095822)

  • Cynthia Wolberger

National Institute of General Medical Sciences (GM064649)

  • Tim Formosa

National Science Foundation (Graduate Research Fellowship)

  • Melesse Nune

Jordan and Irene Tark Academic Chair

  • Ashraf Brik

Israel Council of Higher Education (Fellowship)

  • Muhammad Jbara

National Institute of General Medical Sciences (Training Grant GM008403)

  • Melesse Nune

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2019, Nune et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 8,178
    views
  • 554
    downloads
  • 27
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Melesse Nune
  2. Michael T Morgan
  3. Zaily Connell
  4. Laura McCullough
  5. Muhammad Jbara
  6. Hao Sun
  7. Ashraf Brik
  8. Tim Formosa
  9. Cynthia Wolberger
(2019)
FACT and Ubp10 collaborate to modulate H2B deubiquitination and nucleosome dynamics
eLife 8:e40988.
https://doi.org/10.7554/eLife.40988

Share this article

https://doi.org/10.7554/eLife.40988

Further reading

    1. Biochemistry and Chemical Biology
    2. Stem Cells and Regenerative Medicine
    Alejandro J Brenes, Eva Griesser ... Angus I Lamond
    Research Article

    Human induced pluripotent stem cells (hiPSCs) have great potential to be used as alternatives to embryonic stem cells (hESCs) in regenerative medicine and disease modelling. In this study, we characterise the proteomes of multiple hiPSC and hESC lines derived from independent donors and find that while they express a near-identical set of proteins, they show consistent quantitative differences in the abundance of a subset of proteins. hiPSCs have increased total protein content, while maintaining a comparable cell cycle profile to hESCs, with increased abundance of cytoplasmic and mitochondrial proteins required to sustain high growth rates, including nutrient transporters and metabolic proteins. Prominent changes detected in proteins involved in mitochondrial metabolism correlated with enhanced mitochondrial potential, shown using high-resolution respirometry. hiPSCs also produced higher levels of secreted proteins, including growth factors and proteins involved in the inhibition of the immune system. The data indicate that reprogramming of fibroblasts to hiPSCs produces important differences in cytoplasmic and mitochondrial proteins compared to hESCs, with consequences affecting growth and metabolism. This study improves our understanding of the molecular differences between hiPSCs and hESCs, with implications for potential risks and benefits for their use in future disease modelling and therapeutic applications.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Jie Luo, Jeff Ranish
    Tools and Resources

    Dynamic conformational and structural changes in proteins and protein complexes play a central and ubiquitous role in the regulation of protein function, yet it is very challenging to study these changes, especially for large protein complexes, under physiological conditions. Here, we introduce a novel isobaric crosslinker, Qlinker, for studying conformational and structural changes in proteins and protein complexes using quantitative crosslinking mass spectrometry. Qlinkers are small and simple, amine-reactive molecules with an optimal extended distance of ~10 Å, which use MS2 reporter ions for relative quantification of Qlinker-modified peptides derived from different samples. We synthesized the 2-plex Q2linker and showed that the Q2linker can provide quantitative crosslinking data that pinpoints key conformational and structural changes in biosensors, binary and ternary complexes composed of the general transcription factors TBP, TFIIA, and TFIIB, and RNA polymerase II complexes.